Michael D Belbis, Michael J Holmes, Joseph Yao, Christopher W Kinnick, Christopher K Kargl, Carly Day, Nicole L Noel, Timothy P Gavin, Bruno T Roseguini, Daniel M Hirai
{"title":"急性选择性环氧合酶-2抑制对骨骼肌微血管氧合和运动耐量的影响。","authors":"Michael D Belbis, Michael J Holmes, Joseph Yao, Christopher W Kinnick, Christopher K Kargl, Carly Day, Nicole L Noel, Timothy P Gavin, Bruno T Roseguini, Daniel M Hirai","doi":"10.1113/EP092518","DOIUrl":null,"url":null,"abstract":"<p><p>The cyclooxygenase (COX) pathway regulates vascular tone and, therefore, local O<sub>2</sub> delivery-utilization matching. The two main isoforms, COX-1 and COX-2, may promote opposing effects on contracting muscle O<sub>2</sub> transport in health by inducing vasoconstriction and vasodilatation, respectively. Whether COX-2 and its main vasodilatory product (prostacyclin, PGI<sub>2</sub>) modulate microvascular O<sub>2</sub> transport to skeletal muscle and thus exercise tolerance is unknown. We tested the hypothesis that acute selective COX-2 inhibition (SC2I) would impair cardiorespiratory and skeletal muscle microvascular responses from rest to exercise, thereby reducing exercise tolerance in healthy adults. Twelve individuals participated in a randomized, double-blind, crossover study to receive SC2I (200 mg celecoxib) or placebo (control, CON). Moderate and severe intensity cycling were performed with measurements of heart rate, arterial blood pressure, pulmonary oxygen uptake ( <math> <semantics> <msub><mover><mi>V</mi> <mo>̇</mo></mover> <msub><mi>O</mi> <mn>2</mn></msub> </msub> <annotation>${\\dot V_{{{\\mathrm{O}}_2}}}$</annotation></semantics> </math> ), leg muscle microvascular oxygenation ( <math> <semantics><msub><mi>S</mi> <mrow><mi>t</mi> <msub><mi>O</mi> <mn>2</mn></msub> </mrow> </msub> <annotation>${S_{{\\mathrm{t}}{{\\mathrm{O}}_2}}}$</annotation></semantics> </math> ; near-infrared spectroscopy) and time to exhaustion. Leg muscle <math> <semantics><msub><mi>S</mi> <mrow><mi>t</mi> <msub><mi>O</mi> <mn>2</mn></msub> </mrow> </msub> <annotation>${S_{{\\mathrm{t}}{{\\mathrm{O}}_2}}}$</annotation></semantics> </math> was also assessed during cuff occlusion protocols. SC2I decreased the plasma concentration of the stable PGI<sub>2</sub> metabolite 6-keto prostaglandin F<sub>1α</sub> (CON: 203 (54) pg/mL; SC2I: 108 (54) pg/mL; P = 0.002). There was no difference in exercise tolerance (CON: 278 (55) s; SC2I: 298 (75) s), arterial blood pressure, heart rate, pulmonary <math> <semantics> <msub><mover><mi>V</mi> <mo>̇</mo></mover> <msub><mi>O</mi> <mn>2</mn></msub> </msub> <annotation>${\\dot V_{{{\\mathrm{O}}_2}}}$</annotation></semantics> </math> or leg muscle <math> <semantics><msub><mi>S</mi> <mrow><mi>t</mi> <msub><mi>O</mi> <mn>2</mn></msub> </mrow> </msub> <annotation>${S_{{\\mathrm{t}}{{\\mathrm{O}}_2}}}$</annotation></semantics> </math> from rest to moderate or severe exercise between conditions (P > 0.05 for all). Moreover, there was no significant difference in <math> <semantics><msub><mi>S</mi> <mrow><mi>t</mi> <msub><mi>O</mi> <mn>2</mn></msub> </mrow> </msub> <annotation>${S_{{\\mathrm{t}}{{\\mathrm{O}}_2}}}$</annotation></semantics> </math> during cuff occlusion protocols between conditions. Contrary to our hypothesis, these data indicate that COX-2 is not obligatory for the regulation of skeletal muscle microvascular oxygenation at rest or during moderate or severe intensity exercise, and therefore does not modulate exercise tolerance in healthy adults.</p>","PeriodicalId":12092,"journal":{"name":"Experimental Physiology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of acute selective cyclooxygenase-2 inhibition on skeletal muscle microvascular oxygenation and exercise tolerance.\",\"authors\":\"Michael D Belbis, Michael J Holmes, Joseph Yao, Christopher W Kinnick, Christopher K Kargl, Carly Day, Nicole L Noel, Timothy P Gavin, Bruno T Roseguini, Daniel M Hirai\",\"doi\":\"10.1113/EP092518\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The cyclooxygenase (COX) pathway regulates vascular tone and, therefore, local O<sub>2</sub> delivery-utilization matching. The two main isoforms, COX-1 and COX-2, may promote opposing effects on contracting muscle O<sub>2</sub> transport in health by inducing vasoconstriction and vasodilatation, respectively. Whether COX-2 and its main vasodilatory product (prostacyclin, PGI<sub>2</sub>) modulate microvascular O<sub>2</sub> transport to skeletal muscle and thus exercise tolerance is unknown. We tested the hypothesis that acute selective COX-2 inhibition (SC2I) would impair cardiorespiratory and skeletal muscle microvascular responses from rest to exercise, thereby reducing exercise tolerance in healthy adults. Twelve individuals participated in a randomized, double-blind, crossover study to receive SC2I (200 mg celecoxib) or placebo (control, CON). Moderate and severe intensity cycling were performed with measurements of heart rate, arterial blood pressure, pulmonary oxygen uptake ( <math> <semantics> <msub><mover><mi>V</mi> <mo>̇</mo></mover> <msub><mi>O</mi> <mn>2</mn></msub> </msub> <annotation>${\\\\dot V_{{{\\\\mathrm{O}}_2}}}$</annotation></semantics> </math> ), leg muscle microvascular oxygenation ( <math> <semantics><msub><mi>S</mi> <mrow><mi>t</mi> <msub><mi>O</mi> <mn>2</mn></msub> </mrow> </msub> <annotation>${S_{{\\\\mathrm{t}}{{\\\\mathrm{O}}_2}}}$</annotation></semantics> </math> ; near-infrared spectroscopy) and time to exhaustion. Leg muscle <math> <semantics><msub><mi>S</mi> <mrow><mi>t</mi> <msub><mi>O</mi> <mn>2</mn></msub> </mrow> </msub> <annotation>${S_{{\\\\mathrm{t}}{{\\\\mathrm{O}}_2}}}$</annotation></semantics> </math> was also assessed during cuff occlusion protocols. SC2I decreased the plasma concentration of the stable PGI<sub>2</sub> metabolite 6-keto prostaglandin F<sub>1α</sub> (CON: 203 (54) pg/mL; SC2I: 108 (54) pg/mL; P = 0.002). There was no difference in exercise tolerance (CON: 278 (55) s; SC2I: 298 (75) s), arterial blood pressure, heart rate, pulmonary <math> <semantics> <msub><mover><mi>V</mi> <mo>̇</mo></mover> <msub><mi>O</mi> <mn>2</mn></msub> </msub> <annotation>${\\\\dot V_{{{\\\\mathrm{O}}_2}}}$</annotation></semantics> </math> or leg muscle <math> <semantics><msub><mi>S</mi> <mrow><mi>t</mi> <msub><mi>O</mi> <mn>2</mn></msub> </mrow> </msub> <annotation>${S_{{\\\\mathrm{t}}{{\\\\mathrm{O}}_2}}}$</annotation></semantics> </math> from rest to moderate or severe exercise between conditions (P > 0.05 for all). Moreover, there was no significant difference in <math> <semantics><msub><mi>S</mi> <mrow><mi>t</mi> <msub><mi>O</mi> <mn>2</mn></msub> </mrow> </msub> <annotation>${S_{{\\\\mathrm{t}}{{\\\\mathrm{O}}_2}}}$</annotation></semantics> </math> during cuff occlusion protocols between conditions. Contrary to our hypothesis, these data indicate that COX-2 is not obligatory for the regulation of skeletal muscle microvascular oxygenation at rest or during moderate or severe intensity exercise, and therefore does not modulate exercise tolerance in healthy adults.</p>\",\"PeriodicalId\":12092,\"journal\":{\"name\":\"Experimental Physiology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-03-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Experimental Physiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1113/EP092518\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHYSIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental Physiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1113/EP092518","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHYSIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
环氧合酶(COX)途径调节血管张力,从而调节局部氧输送-利用匹配。COX-1和COX-2这两种主要亚型可能分别通过诱导血管收缩和血管舒张来促进健康状态下收缩肌肉氧转运的相反作用。COX-2及其主要血管舒张产物(前列腺环素,PGI2)是否调节微血管O2向骨骼肌的转运,从而调节运动耐量尚不清楚。我们验证了急性选择性COX-2抑制(SC2I)会损害从休息到运动的心肺和骨骼肌微血管反应,从而降低健康成人的运动耐量的假设。12人参加了一项随机、双盲、交叉研究,接受SC2I (200 mg塞来昔布)或安慰剂(对照组,CON)。进行中、重度运动,测量心率、动脉血压、肺摄氧量(V * O 2 ${\dot V_{{\ mathm {O}}_2}}}$)、腿部肌肉微血管氧合(S * O 2 ${S_{\ mathm {t}}{{\ mathm {O}}_2}}}$;近红外光谱)和时间耗尽。小腿肌肉S t O 2 ${S_{\mathrm{t}}{{\mathrm{O}}_2}}}$也在袖带闭塞方案中进行评估。SC2I降低PGI2稳定代谢物6-酮前列腺素F1α的血浆浓度(CON: 203 (54) pg/mL;SC2I: 108 (54) pg/mL;p = 0.002)。运动耐量没有差异(CON: 278 (55) s;SC2I: 298 (75) s)、动脉血压、心率、肺V (O) 2 ${\dot V_{{\mathrm{O}}_2}}}$或腿部肌肉s (O) 2 ${S_{\mathrm{t}}{{\mathrm{O}}_2}}}$从休息到中度或重度运动(P < 0.05)。此外,在不同条件下,袖带闭塞方案的S t O 2 ${S_{\mathrm{t}}{{\mathrm{O}}_2}}}$无显著差异。与我们的假设相反,这些数据表明COX-2在休息或中等或高强度运动时对骨骼肌微血管氧合的调节不是强制性的,因此不会调节健康成人的运动耐量。
Effects of acute selective cyclooxygenase-2 inhibition on skeletal muscle microvascular oxygenation and exercise tolerance.
The cyclooxygenase (COX) pathway regulates vascular tone and, therefore, local O2 delivery-utilization matching. The two main isoforms, COX-1 and COX-2, may promote opposing effects on contracting muscle O2 transport in health by inducing vasoconstriction and vasodilatation, respectively. Whether COX-2 and its main vasodilatory product (prostacyclin, PGI2) modulate microvascular O2 transport to skeletal muscle and thus exercise tolerance is unknown. We tested the hypothesis that acute selective COX-2 inhibition (SC2I) would impair cardiorespiratory and skeletal muscle microvascular responses from rest to exercise, thereby reducing exercise tolerance in healthy adults. Twelve individuals participated in a randomized, double-blind, crossover study to receive SC2I (200 mg celecoxib) or placebo (control, CON). Moderate and severe intensity cycling were performed with measurements of heart rate, arterial blood pressure, pulmonary oxygen uptake ( ), leg muscle microvascular oxygenation ( ; near-infrared spectroscopy) and time to exhaustion. Leg muscle was also assessed during cuff occlusion protocols. SC2I decreased the plasma concentration of the stable PGI2 metabolite 6-keto prostaglandin F1α (CON: 203 (54) pg/mL; SC2I: 108 (54) pg/mL; P = 0.002). There was no difference in exercise tolerance (CON: 278 (55) s; SC2I: 298 (75) s), arterial blood pressure, heart rate, pulmonary or leg muscle from rest to moderate or severe exercise between conditions (P > 0.05 for all). Moreover, there was no significant difference in during cuff occlusion protocols between conditions. Contrary to our hypothesis, these data indicate that COX-2 is not obligatory for the regulation of skeletal muscle microvascular oxygenation at rest or during moderate or severe intensity exercise, and therefore does not modulate exercise tolerance in healthy adults.
期刊介绍:
Experimental Physiology publishes research papers that report novel insights into homeostatic and adaptive responses in health, as well as those that further our understanding of pathophysiological mechanisms in disease. We encourage papers that embrace the journal’s orientation of translation and integration, including studies of the adaptive responses to exercise, acute and chronic environmental stressors, growth and aging, and diseases where integrative homeostatic mechanisms play a key role in the response to and evolution of the disease process. Examples of such diseases include hypertension, heart failure, hypoxic lung disease, endocrine and neurological disorders. We are also keen to publish research that has a translational aspect or clinical application. Comparative physiology work that can be applied to aid the understanding human physiology is also encouraged.
Manuscripts that report the use of bioinformatic, genomic, molecular, proteomic and cellular techniques to provide novel insights into integrative physiological and pathophysiological mechanisms are welcomed.